Rani Therapeutics Holdings, Inc.
RANI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001856725
In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Rani Therapeutics Holdings, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +7 vs. Q3 2021
- Shares held
- 1.24M
- +143.2K (+13.0%) vs. Q3 2021
- Total value
- $20.3M
- +$725.0K (+3.7%) vs. Q3 2021
- New holders
- 10
- 5 more added
- Sold out
- 3
- 3 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RANI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 68 | $34.7M |
| Q1 2026 | 74 | $31.4M |
| Q4 2025 | 64 | $60.5M |
| Q3 2025 | 38 | $2.02M |
| Q2 2025 | 39 | $3.32M |
| Q1 2025 | 38 | $4.58M |
| Q4 2024 | 42 | $5.23M |
| Q3 2024 | 31 | $12.8M |
| Q2 2024 | 34 | $11.8M |
| Q1 2024 | 37 | $10.7M |
| Q4 2023 | 34 | $10.9M |
| Q3 2023 | 34 | $6.96M |
| Q2 2023 | 35 | $13.3M |
| Q1 2023 | 36 | $15.5M |
| Q4 2022 | 34 | $17.6M |
| Q3 2022 | 32 | $30.4M |
| Q2 2022 | 28 | $29.1M |
| Q1 2022 | 24 | $34.5M |
| Q4 2021 | 22 | $20.3M |
| Q3 2021 | 15 | $19.6M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Rani Therapeutics Holdings, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nan Fung Group Holdings Ltd | 493,584 | $8.07M | 2.39% | 00.0% | Unchanged |
| Vanguard Group Inc | 285,546 | $4.67M | 0.00% | +2,333+0.8% | Added |
| BlackRock Inc. | 114,298 | $1.87M | 0.00% | +114,298 | New |
| Alpha Square Group S, LLC | 101,603 | $1.66M | 0.34% | +101,603 | New |
| Geode Capital Management, LLC | 63,217 | $1.03M | 0.00% | +41,578+192.1% | Added |
| Squarepoint Ops LLC | 50,000 | $818.0K | 0.00% | 00.0% | Unchanged |
| Stifel Financial Corp | 40,050 | $655.0K | 0.00% | +2,100+5.5% | Added |
| Advisor Group Holdings, Inc. | 21,072 | $344.0K | 0.00% | +21,072 | New |
| State Street Corp | 19,700 | $322.0K | 0.00% | 00.0% | Unchanged |
| Caas Capital Management LP | 13,934 | $228.0K | 0.02% | −61,066−81.4% | Reduced |
| Northern Trust Corp | 11,430 | $187.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,191 | $85.0K | 0.00% | +2,121+69.1% | Added |
| Canton Hathaway, LLC | 5,000 | $82.0K | 0.02% | −5,000−50.0% | Reduced |
| Bank of America Corp | 4,422 | $73.0K | 0.00% | +2,955+201.4% | Added |
| JPMorgan Chase & Co | 4,186 | $68.0K | 0.00% | +4,186 | New |
| Morgan Stanley | 3,773 | $61.0K | 0.00% | +3,773 | New |
| Tower Research Capital LLC (TRC) | 2,646 | $43.0K | 0.00% | +2,646 | New |
| Citigroup Inc | 864 | $14.0K | 0.00% | +864 | New |
| The PNC Financial Services Group, Inc. | 300 | $5.00K | 0.00% | +300 | New |
| Signaturefd, LLC | 65 | $1.00K | 0.00% | +65 | New |
| Daiwa Securities Group Inc. | 58 | $1.00K | 0.00% | +58 | New |
| Wells Fargo & Company | 1 | $0 | 0.00% | −39−97.5% | Reduced |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −60,649−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −28,996−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |